This page includes the latest FDA filings for Halozyme Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | HALO | DUNS 026077359 |
Device Company | Device | Date |
|---|---|---|
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2024-01-29 |
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2024-01-17 |
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2023-07-20 |
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2021-05-01 |
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2020-06-25 |
| Antares Pharma, Inc., Patheon Manufacturing Services LLC | Prescription Medication | 2019-07-09 |
| Halozyme Therapeutics, Inc. | HYLENEX Recombinant | 2005-12-02 |
HALOZYME THERAPEUTICS INC. | CUMULASE | 2005-04-14 |
| CAGE Code | 5N8N3 | HALOZYME THERAPEUTICS, INC. RESEARCH |
| S.A.M. Registration | 5N8N3 [26077359] | HALOZYME THERAPEUTICS, INC. |
| SEC | 0001159036 | HALOZYME THERAPEUTICS, INC. of DELAWARE |